- Home
- AKRO vs DLO Comparison
AKRO vs DLO Comparison
Compare AKRO & DLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- DLO
- Stock Information
- Founded
- AKRO 2017
- DLO 2013
- Country
- AKRO United States
- DLO Uruguay
- Employees
- AKRO N/A
- DLO N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- DLO Business Services
- Sector
- AKRO Health Care
- DLO Consumer Discretionary
- Exchange
- AKRO Nasdaq
- DLO Nasdaq
- Market Cap
- AKRO 3.7B
- DLO 4.0B
- IPO Year
- AKRO 2019
- DLO 2021
- Fundamental
- Price
- AKRO $46.50
- DLO $14.11
- Analyst Decision
- AKRO Strong Buy
- DLO Buy
- Analyst Count
- AKRO 8
- DLO 9
- Target Price
- AKRO $80.38
- DLO $13.44
- AVG Volume (30 Days)
- AKRO 1.2M
- DLO 2.2M
- Earning Date
- AKRO 11-07-2025
- DLO 11-12-2025
- Dividend Yield
- AKRO N/A
- DLO 3.62%
- EPS Growth
- AKRO N/A
- DLO 9.30
- EPS
- AKRO N/A
- DLO 0.48
- Revenue
- AKRO N/A
- DLO $863,482,000.00
- Revenue This Year
- AKRO N/A
- DLO $38.48
- Revenue Next Year
- AKRO N/A
- DLO $27.49
- P/E Ratio
- AKRO N/A
- DLO $29.42
- Revenue Growth
- AKRO N/A
- DLO 22.02
- 52 Week Low
- AKRO $21.34
- DLO $7.61
- 52 Week High
- AKRO $58.40
- DLO $16.44
- Technical
- Relative Strength Index (RSI)
- AKRO 47.87
- DLO 53.28
- Support Level
- AKRO $45.20
- DLO $13.95
- Resistance Level
- AKRO $47.40
- DLO $14.80
- Average True Range (ATR)
- AKRO 1.46
- DLO 0.54
- MACD
- AKRO 0.06
- DLO -0.13
- Stochastic Oscillator
- AKRO 34.90
- DLO 32.12
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About DLO DLocal Limited
DLocal Ltd is focused on making the complex simple, redefining the online payment experience in emerging markets. Through its technology platform, One dLocal, the company enables world-wide enterprise merchants to get paid (pay-in) and to make payments (pay-out) online in a safe and efficient manner. The company earns revenue from fees charged to merchants in connection with payment processing services for cross-border and local payment transactions. The company's geographical segments include Latin America and Non-Latin America with a majority of its revenue being generated from Brazil in Latin America region.